The vector of anti-MAGE-A3 T cell receptor (TCR) is constructed for the engineering of T cell to target Human MAGE-A3. The T cells are genetically modified through transduction with a lentiviral vector expressing MAGE-A3-specific T cell receptor. And the vector product was designed for the treatment of Melanmoma.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|TCR-L359||Human anti-MAGE-A3 T cell receptor (EB81-103), pCDTCR1|
|TCR-C125Z||Human anti-MAGE-A3 (EVDPIGHLY) T cell receptor (Affinity enhanced), pCDTCR1|
|TCR-C129Z||Human anti-MAGE-A3 T cell receptor (TCRVα38/Vβ2), pCDTCR1|
|TCR-L062||Human anti-MAGEA3 (EVDPIGHLY) T Cell Receptor, pMSGV1|
|VP-TCR-C243||Lenti-MAGE-A3 T cell receptor (6F9) Viral Particle|
|VP-TCR-C245||Lenti-MAGE-A3 T cell receptor (ESBI 648) Viral Particle|
|VP-TCR-C239||Lenti-MAGE-A3 (KVAELVHFL) T cell receptor (Affinity enhanced) Viral Particle|
|TCR-C130Z||Human anti-MAGE-A3 T cell receptor (TCRVα3/Vβ28), pCDTCR1|
|VP-TCR-C246||Lenti-MAGE-A3 T cell receptor (TCRVα38/Vβ2) Viral Particle|
|VP-TCR-C247||Lenti-MAGE-A3 T cell receptor (TCRVα3/Vβ28) Viral Particle|
Copyright © 2007 - 2018 Creative Biolabs. All Rights Reserved